QUALITY INGREDIENTS: Made with Reduced L-Glutathione (GSH) and no proprietary blends
Most patients lose 2-4 pounds monthly during initial dose escalation, with cumulative monthly averages reaching 3-5 pounds as doses increase toward the 2.4 mg maintenance level
Nutritional support is critical in patients with prolonged cholestasis, especially because they are at risk for the development of biliary cirrhosis and liver failure
In patients with locally advanced, metastatic, and/or refractory solid tumors and hematological malignancies, CB839 is being evaluated in open-label phase I clinical trials (NCT02071862, NCT02071888, NCT02771626)
The compound is sold exclusively as a research peptide , meaning it is intended only for laboratory experiments and scientific investigation conducted by qualified professionals
It also highlighted how online health information, while sometimes helpful, can lead patients astray when not properly vetted or understood